Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 3

Abstract

Introduction: There is scarcity of data in literature regarding the treatment response with Sofosbuvir (SOF) based therapy in Indian patients with chronic Hepatitis-C Virus (HCV) infection. Aim: This study was designed to observe initial treatment response to SOF based therapy in a “real-life” cohort of Indian patients with HCV infection. Materials and Methods: This is a prospective, observational and single center study. A total of 107 patients who were diagnosed with chronic HCV infection and received SOF based treatment between March 2015 and December 2015 were included. The patients were treated with either triple drug regimen [SOF, Ribavirin (RBV) and Pegylated Interferon-α (Peg IFN-α)] or dual drug regimen (SOF and RBV) for either 12 or 24 weeks. The virological responses were obtained at baseline and thereafter weekly (up to four weeks) till viral load became undetected during treatment. Results: A total of 107 patients who received SOF based therapy for chronic HCV infection were included in the study. Mean age of the patients was 48.7±10.7 years. Among included patients, 24 (22.4%) patients were treatment-experienced. Majority of the patients (n=69; 64.5%) were infected with HCV genotype-3. Except one patient, all the included patients achieved virological response up to week-4 of the treatment. There was statistically insignificant association between virological response (up to four week of the treatment) and severity of the disease (cirrhosis and non-cirrhosis) or treatment status (treatment-naïve and treatment-experienced), or HCV genotype (genotype-1 and 3). Conclusion: The results of this observational study demonstrated rapid initial virological response of SOF based therapy in “real-life” cohort of Indian patients with chronic HCV infection. However, long-term follow-up data are needed to ensure the sustained antiviral efficacy of SOF based therapy.

Authors and Affiliations

Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania

Keywords

Related Articles

Understanding Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: A Critical Update in Development of New Approaches

ABSTRACT Cancer Stem Cells (CSCs) have an important role in Head and Neck Squamous Cell Carcinoma (HNSCC). HNSCC is considered as one of the major health problems throughout the world. These self-renewing cells are respo...

Comparative Evaluation of The Efficacy of Aloe Vera Gel with Milk and Hank’s Balanced Salt Solution in Maintaining the Viability of PDL Cells in Avulsed Teeth

ABSTRACT Introduction: Various storage media have been investigated due to their ability to maintain the viability of the Periodontal Ligament (PDL) cells, thus permitting longer extra-alveolar periods prior to replantat...

A Study on the Knowledge, Attitude and Practices Regarding Menstrual Hygiene among Adolescent Girls in Schools in a Rural Area of Goa

ABSTRACT Introduction: Menstruation is a natural physiological process surrounded by myths and taboos which often lead to misconceptions and faulty knowledge and practices in menstruation. Along with social and cultural...

Role of a Prosthodontist in Forensic Dentistry- A Step towards Evolution

ABSTRACT In Forensic odontology, dentistry plays a significant role in the identification of victims in the process of law and order. Dental identification serves as a primary mean for the identification of victim when o...

Polymorphism in the Eruption Sequence of Primary Dentition: A Cross-sectional Study

Introduction: Primary teeth have shown wide variations in their eruption time among different population. Population specific eruption ages are provided as mean with standard deviations or median ages with its percentile...

Download PDF file
  • EP ID EP334376
  • DOI 10.7860/JCDR/2017/23184.9335
  • Views 79
  • Downloads 0

How To Cite

Rajiv Mehta, Mayank Kabrawala, Subhash Nandwani, Rini Tekriwal, Payal Nandania (2017). Early Experience of Sofosbuvir based Combination Therapy in “Real-Life” Cohort with Chronic Hepatitis-C Infection. Journal of Clinical and Diagnostic Research, 11(3), 5-8. https://europub.co.uk/articles/-A-334376